Intraaortic Balloon Counterpulsation: A Review of Physiological Principles, Clinical Results, and Device Safety

Karl Weber, Joseph S. Janicki

Research output: Contribution to journalReview article

126 Citations (Scopus)

Abstract

The intraaortic balloon counterpulsation device (IAB) has been used in the treatment of several hundred patients with acute myocardial infarction shock and other conditions complicating the course of ischemic heart disease and characterized by low-output failure. With the balloon positioned in the thoracic aorta, synchronous inflation-deflation occurs during cardiac diastole and systole, respectively, thereby augmenting aortic diastolic or coronary perfusion pressure and reducing the impedance to ventricular ejection. The extent to which the fixed-volume IAB system can thus alter the circulatory physiology is a function of a number of mechanical and biological variables. In more than 80% of patients with infarction, the shock state may be reversed; however, the majority of these patients have been IAB-dependent. Complications during IAB support, while infrequent, have included aortic wall damage, femoral artery insufficiency, and thrombocytopenia. This review summarizes the major aspects and current status of this cardiocirculatory supportive device.

Original languageEnglish (US)
Pages (from-to)602-636
Number of pages35
JournalAnnals of Thoracic Surgery
Volume17
Issue number6
DOIs
StatePublished - Jan 1 1974

Fingerprint

Equipment Safety
Counterpulsation
Shock
Equipment and Supplies
Diastole
Systole
Economic Inflation
Femoral Artery
Electric Impedance
Thoracic Aorta
Thrombocytopenia
Infarction
Myocardial Ischemia
Perfusion
Myocardial Infarction
Pressure
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Intraaortic Balloon Counterpulsation : A Review of Physiological Principles, Clinical Results, and Device Safety. / Weber, Karl; Janicki, Joseph S.

In: Annals of Thoracic Surgery, Vol. 17, No. 6, 01.01.1974, p. 602-636.

Research output: Contribution to journalReview article

@article{15d8b939ff6a4e0da43bae6c957339a2,
title = "Intraaortic Balloon Counterpulsation: A Review of Physiological Principles, Clinical Results, and Device Safety",
abstract = "The intraaortic balloon counterpulsation device (IAB) has been used in the treatment of several hundred patients with acute myocardial infarction shock and other conditions complicating the course of ischemic heart disease and characterized by low-output failure. With the balloon positioned in the thoracic aorta, synchronous inflation-deflation occurs during cardiac diastole and systole, respectively, thereby augmenting aortic diastolic or coronary perfusion pressure and reducing the impedance to ventricular ejection. The extent to which the fixed-volume IAB system can thus alter the circulatory physiology is a function of a number of mechanical and biological variables. In more than 80{\%} of patients with infarction, the shock state may be reversed; however, the majority of these patients have been IAB-dependent. Complications during IAB support, while infrequent, have included aortic wall damage, femoral artery insufficiency, and thrombocytopenia. This review summarizes the major aspects and current status of this cardiocirculatory supportive device.",
author = "Karl Weber and Janicki, {Joseph S.}",
year = "1974",
month = "1",
day = "1",
doi = "10.1016/S0003-4975(10)65706-2",
language = "English (US)",
volume = "17",
pages = "602--636",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Intraaortic Balloon Counterpulsation

T2 - A Review of Physiological Principles, Clinical Results, and Device Safety

AU - Weber, Karl

AU - Janicki, Joseph S.

PY - 1974/1/1

Y1 - 1974/1/1

N2 - The intraaortic balloon counterpulsation device (IAB) has been used in the treatment of several hundred patients with acute myocardial infarction shock and other conditions complicating the course of ischemic heart disease and characterized by low-output failure. With the balloon positioned in the thoracic aorta, synchronous inflation-deflation occurs during cardiac diastole and systole, respectively, thereby augmenting aortic diastolic or coronary perfusion pressure and reducing the impedance to ventricular ejection. The extent to which the fixed-volume IAB system can thus alter the circulatory physiology is a function of a number of mechanical and biological variables. In more than 80% of patients with infarction, the shock state may be reversed; however, the majority of these patients have been IAB-dependent. Complications during IAB support, while infrequent, have included aortic wall damage, femoral artery insufficiency, and thrombocytopenia. This review summarizes the major aspects and current status of this cardiocirculatory supportive device.

AB - The intraaortic balloon counterpulsation device (IAB) has been used in the treatment of several hundred patients with acute myocardial infarction shock and other conditions complicating the course of ischemic heart disease and characterized by low-output failure. With the balloon positioned in the thoracic aorta, synchronous inflation-deflation occurs during cardiac diastole and systole, respectively, thereby augmenting aortic diastolic or coronary perfusion pressure and reducing the impedance to ventricular ejection. The extent to which the fixed-volume IAB system can thus alter the circulatory physiology is a function of a number of mechanical and biological variables. In more than 80% of patients with infarction, the shock state may be reversed; however, the majority of these patients have been IAB-dependent. Complications during IAB support, while infrequent, have included aortic wall damage, femoral artery insufficiency, and thrombocytopenia. This review summarizes the major aspects and current status of this cardiocirculatory supportive device.

UR - http://www.scopus.com/inward/record.url?scp=0016156362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016156362&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(10)65706-2

DO - 10.1016/S0003-4975(10)65706-2

M3 - Review article

C2 - 4601521

AN - SCOPUS:0016156362

VL - 17

SP - 602

EP - 636

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -